Clinical Brief: Safety of Lipid-Lowering Therapies
This Brief summarizes four studies that examine the safety of HMG-CoA reductase inhibitors (statins). It also includes an analysis for MCOs by Steven R. Peskin, MD, MBA.
Highlights:
- The Report of the National Lipid Association Statin Safety Task Force
- International Studies on the Comparative Safety of Rosuvastatin
More like this
- Clinical Brief: A Single Tablet to Help Manage Patients With Hypertension and Other Cardiovascular Risk Factors
- Clinical Brief: Abatacept for Rheumatoid Arthritis
- Clinical Brief: The Etiology of Menstrual Migraine
- Clinical Brief: The Unique Burden of Menstrual Migraine
- Managed Care Trends in Statin Usage
